Investor Relations

OPKO To Announce Second Quarter Operating and Financial Results on August 5, 2015 more »

FDA Accepts OPKO's New Drug Application for Rayaldee™ more »

OPKO Announces Completion of Enrollment in Phase 3 Trial of hGH-CTP in Growth Hormone Deficient Adults more »

OPKO Investee SciVac Announces the Completion of Transaction with Levon Resources more »

Conferences & Events

Upcoming Event
Aug 5, 2015
4:30 PM ET
OPKO Second Quarter 2015 Financial Results
Webcast Listen to webcast
Reminder Remind me

Archived Events
Jun 11, 2015
8:30 AM ET
OPKO Health and Bio-Reference Laboratories
Webcast Listen to webcast
Jun 3, 2015
4:00 PM
Jefferies 2015 Healthcare Conference
Webcast Listen to webcast
PDF View Presentation  2.9 MB